Steve Anderson has been writing professionally for the last 15 years. His background in financial writing covers a wide range of sub-sectors; he's covered consumer tech, communications technology, banking products, mobile payments, and many other fields giving him perspective into markets from retail to tech to pharmaceutical and beyond. Contact Steve Anderson via email at [email protected]
Gilead Sciences (NASDAQ:GILD) Expands its Focus Beyond Covid
September 17th, 2020 1:00 AM
The race to a vaccine for the novel coronavirus that shut down so much of the nation and left us all a little bit more wary than we were this time last year is tightening up, and Gilead Sciences (NASDAQ:GILD) isn't exactly at the front of the pack right now.
Microsoft (NASDAQ:MSFT) Facing Challenges Ahead
August 31st, 2020 1:00 AM
Microsoft (NASDAQ:MSFT) is a global juggernaut that should be above make-or-break cycles. The notion that Microsoft could face breaking at all might sound casually ludicrous to some,
Digital Turbine (NASDAQ:APPS) A Highly Volatile Buy
August 28th, 2020 5:10 AM
One company that's seen some staggering gains—and a few less-staggering losses—is Digital Turbine (NASDAQ: APPS), a company that's delivered a lot of value, but not without some hiccups along the way.
Qorvo (NASDAQ:QRVO) Will Be One Wild Buy
August 27th, 2020 1:00 AM
That's just what's going on with Qorvo (NASDAQ:QRVO), which is turning in big expectations in pretty much every direction simultaneously.
Best Buy (BBY) Proves to be a Best Buy For the Risk-Averse
August 25th, 2020 1:00 AM
Best Buy (NYSE:BBY) may be a physical retail stock in an increasingly online shopping world, and a big-box retailer at that, but it's increasingly demonstrating that it's got its investors' fortunes in mind.
Tempted by Inovio Pharmaceuticals (NASDAQ:INO)?
August 11th, 2020 1:00 AM
It would be easy to be tempted by Inovio Pharmaceuticals (NASDAQ:INO) , a little biotech company out of Pennsylvania that's part of the seemingly endless fray to produce a coronavirus vaccine.
Retail Recovery Carries On for Second Straight Month
July 16th, 2020 1:00 AM
along with the rest of the pent-up demand, gave retail sales another bump in June of 7.5%, which is actually 1.1% higher than it was this time last June. It was also about 50% better than what Reuters economists were offering as a consensus, at 5% gains.